Condition
Nanoplastics
Total Trials
6
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Recruiting3
Not Yet Recruiting2
Unknown1
Clinical Trials (6)
Showing 6 of 6 trials
NCT07291609Recruiting
Microplastics and Nanoplastics in Patients With Chronic Coronary Syndromes
NCT07280390Not Yet Recruiting
Microplastics, Cirrhosis and Portal Hypertension
NCT06965023Recruiting
Microplastics and Nanoplastics (MNPs) in Patients With ST-elevation Myocardial Infarction (STEMI)
NCT05155267Recruiting
Biomonitoring of Internal Exposure to MNPLs, and Its Effects, in Blood of Patients With Chronic Kidney Disease (CKD)
NCT05910489Not Yet Recruiting
Micro and Nanoplastics in Greenhouse Workers: Biomarkers of Exposure and Effect
NCT05600010Unknown
Detection of Microplastics in Cardiac Surgery Patients
Showing all 6 trials